Ac-semax

1 study on Ac-semax curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Ac-semax. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Ac-semax studies and clinical research

2026-04-03 PubMed · in vitro · n preclinical

N-terminus acetylation of Semax alters its copper coordination, redox stability, and neuroprotective effects against copper toxicity.

The findings demonstrate that the free N-terminal amino group of Semax is indispensable for its neuroprotective activity against copper-induced toxicity. For users, this implies that **acetylated Semax (Ac-Semax) is n…

Research tools

Free, no account — handy when you're working with Ac-semax.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$14 monthly or $88/year

Create an account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Ac-semax studies and clinical research

N-terminus acetylation of Semax alters its copper coordination, redox stability, and neuroprotective effects against copper toxicity.

Research tools